- Home
- LPAA vs SMLR Comparison
LPAA vs SMLR Comparison
Compare LPAA & SMLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPAA
- SMLR
- Stock Information
- Founded
- LPAA 2024
- SMLR 2007
- Country
- LPAA United States
- SMLR United States
- Employees
- LPAA N/A
- SMLR N/A
- Industry
- LPAA
- SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LPAA
- SMLR Health Care
- Exchange
- LPAA Nasdaq
- SMLR Nasdaq
- Market Cap
- LPAA 286.9M
- SMLR 289.5M
- IPO Year
- LPAA 2024
- SMLR 2014
- Fundamental
- Price
- LPAA $10.03
- SMLR $71.84
- Analyst Decision
- LPAA
- SMLR
- Analyst Count
- LPAA 0
- SMLR 0
- Target Price
- LPAA N/A
- SMLR N/A
- AVG Volume (30 Days)
- LPAA 87.7K
- SMLR 1.1M
- Earning Date
- LPAA 01-01-0001
- SMLR 11-04-2024
- Dividend Yield
- LPAA N/A
- SMLR N/A
- EPS Growth
- LPAA N/A
- SMLR N/A
- EPS
- LPAA N/A
- SMLR 2.04
- Revenue
- LPAA N/A
- SMLR $58,938,000.00
- Revenue This Year
- LPAA N/A
- SMLR N/A
- Revenue Next Year
- LPAA N/A
- SMLR N/A
- P/E Ratio
- LPAA N/A
- SMLR $31.66
- Revenue Growth
- LPAA N/A
- SMLR N/A
- 52 Week Low
- LPAA $9.66
- SMLR $20.88
- 52 Week High
- LPAA $10.05
- SMLR $79.45
- Technical
- Relative Strength Index (RSI)
- LPAA N/A
- SMLR 67.75
- Support Level
- LPAA N/A
- SMLR $58.75
- Resistance Level
- LPAA N/A
- SMLR $65.97
- Average True Range (ATR)
- LPAA 0.00
- SMLR 7.71
- MACD
- LPAA 0.00
- SMLR -0.05
- Stochastic Oscillator
- LPAA 0.00
- SMLR 72.28
About LPAA Launch One Acquisition Corp. Class A Ordinary shares
Launch One Acquisition Corp is a blank check company.
About SMLR Semler Scientific Inc.
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.